Venker Eric: insider trades.
Venker Eric reported 9 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($14.3M), across 2 companies.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 2
- Name as filed
- Venker Eric
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Roivant Sciences Ltd. (ROIV) | Officer · President & Immunovant CEO | 6 |
| Immunovant, Inc. (IMVT) | Director, Officer · Chief Executive Officer | 3 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-28 | Roivant Sciences Ltd. | S | 166,182 | $35.63 | 1,632,972 | Form 4 |
| 2026-08-28 | Roivant Sciences Ltd. | M | 200,000 | $3.85 | 1,799,154 | Form 4 |
| 2026-08-28 | Roivant Sciences Ltd. | S | 33,818 | $36.44 | 1,599,154 | Form 4 |
| 2026-08-20 | Roivant Sciences Ltd. | F | 13,909 | $36.84 | 1,599,154 | Form 4 |
| 2026-07-27 | Roivant Sciences Ltd. | S | 200,000 | $34.95 | 1,613,063 | Form 4 |
| 2026-07-27 | Roivant Sciences Ltd. | M | 200,000 | $3.85 | 1,813,063 | Form 4 |
| 2026-07-02 | Immunovant, Inc. | S | 3,092 | $38.48 | 254,280 | Form 4 |
| 2026-07-01 | Immunovant, Inc. | D | 86,629 | $38.14 | 257,372 | Form 4 |
| 2026-07-01 | Immunovant, Inc. | M | 92,188 | $14.46 | 344,001 | Form 4 |
Questions
What stock did Venker Eric buy or sell?
Venker Eric reported 9 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($14.3M), across 2 companies.
Is Venker Eric the same person as other filers with this name?
This page covers SEC CIK 1801917 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/venker-eric-1801917.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.